Follicum Phase 2 Trials Update
Sometimes, news items concerning important developments in the hair loss cure world suddenly bombard us like an incessant rainfall. This is certainly the case so far this month. Always a great feeling to get this type of drenching, but makes me spend way too much time updating this blog! Earlier today a commentator named “Camaro” notified us that Sweden based Follicum’s latest investor presentation from the BioStock conference in Sweden was already available on youtube.
Although I just wrote a post earlier today, I decided to add this short one too since the below presentation by Follicum is worth a look. I have covered this company and its FOL-005 hair loss product many times on this blog in the past. My February post that discussed Follicum is worth a reread. Currently, FOL-005 is in Phase IIA clinical trials.
Once you press play, the below video will start right after company CEO Jan Alenfall arrives on stage. Some very interesting slides in the presentation, including one with the clear implication that, at best, this product will work slightly better than Minoxidil. Such an upfront declaration makes me trust the company more. The biggest news is that they are seeing a 75 percent patient response rate in initial results! I am on Follicum’s mailing list and will add a link to the slides if they send those.
